Drug Trial Radar · NCT01774045
A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
Last checked: Nov 20, 2026Latest source record: Aug 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Nov 2012
Primary completion
Jul 2013
Study completion Jul 2013
Sponsor
- Lead sponsor
- BioLite, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 23, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of PDC-1421 Capsule in healthy subject, find the effective adequate dose for the next stage of the study, and accumulate information of possible mechanism of its anti-depressive effect.
Conditions
- Major Depressive Disorder
Interventions
PDC-1421Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Dose Limiting Toxicity of Physical ExaminationTime frame: baseline to 72 hours
- Number of Dose Limiting Toxicity of ElectrocardiographTime frame: baseline to 72 hours
- Number of Dose Limiting Toxicity of Vital SignTime frame: baseline to 72 hours
- Number of Dose Limiting Toxicity of Laboratory ValuesTime frame: baseline to 72 hours
- Number of Dose Limiting Toxicity of Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: baseline to 72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Taipei Veterans General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.